What is she best known for?
The fields of study she is best known for:
- Antibody
- Gene
- Immune system
Her scientific interests lie mostly in Immunology, Molecular biology, Antibody, Antigen and Immunotoxin.
Her Immunology research incorporates themes from Internal medicine, Transplantation and Stem cell.
Her Molecular biology study combines topics in areas such as T cell, Lymphokine, Immunoglobulin M, Surface Immunoglobulin and Cytotoxic T cell.
As a part of the same scientific family, Ellen S. Vitetta mostly works in the field of Antibody, focusing on Spleen and, on occasion, Cell.
Her Antigen study deals with B cell intersecting with B-1 cell.
Her work carried out in the field of Immunotoxin brings together such families of science as Lymphoma, Pathology, Cancer research and Ricin.
Her most cited work include:
- Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells (778 citations)
- Redesigning nature's poisons to create anti-tumor reagents. (496 citations)
- HER-2 gene amplification can be acquired as breast cancer progresses. (470 citations)
What are the main themes of her work throughout her whole career to date?
Ellen S. Vitetta mainly investigates Molecular biology, Immunology, Antibody, Antigen and Immunotoxin.
She combines subjects such as B-1 cell, T cell, B cell, Immunoglobulin D and Cytotoxic T cell with her study of Molecular biology.
Her studies examine the connections between Immunology and genetics, as well as such issues in Transplantation, with regards to Stem cell.
Her work deals with themes such as Cell culture and Virology, which intersect with Antibody.
Ellen S. Vitetta combines subjects such as Immunoprecipitation, Spleen, Receptor and CD40 with her study of Antigen.
Her Immunotoxin research focuses on Ricin and how it relates to Recombinant DNA.
She most often published in these fields:
- Molecular biology (41.35%)
- Immunology (35.98%)
- Antibody (32.60%)
What were the highlights of her more recent work (between 2002-2021)?
- Immunology (35.98%)
- Monoclonal antibody (17.69%)
- Antibody (32.60%)
In recent papers she was focusing on the following fields of study:
Her primary scientific interests are in Immunology, Monoclonal antibody, Antibody, Ricin and Immunotoxin.
The various areas that Ellen S. Vitetta examines in her Immunology study include Stem cell, Transplantation and Graft-versus-host disease.
The concepts of her Monoclonal antibody study are interwoven with issues in Molecular biology, Cancer research, Cell culture and In vivo.
As part of her studies on Molecular biology, she often connects relevant areas like B cell.
Her work carried out in the field of Antibody brings together such families of science as In vitro and Lethal dose.
Her Immunotoxin study also includes fields such as
- Cytotoxic T cell which intersects with area such as Antigen and Gp41,
- Chemotherapy which connect with Anti-CD19 immunotoxin.
Between 2002 and 2021, her most popular works were:
- HER-2 gene amplification can be acquired as breast cancer progresses. (470 citations)
- Thermal ablation of tumor cells with antibody-functionalized single-walled carbon nanotubes (300 citations)
- Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation (224 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Antibody
- Immune system
Ellen S. Vitetta mainly focuses on Immunology, Antibody, Monoclonal antibody, Internal medicine and Immunotoxin.
Her Immunology research includes themes of In vivo and Graft-versus-host disease, Transplantation.
Her studies in Antibody integrate themes in fields like Clinical trial, Recombinant DNA, Ricin and Virology.
Her research in Monoclonal antibody intersects with topics in Epitope, Cell culture, In vitro and Immunoglobulin G.
Her In vitro study incorporates themes from Molecular biology, Biophysics and Monoclonal.
Her Immunotoxin study combines topics in areas such as Cancer research and Refractory.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
